SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
31-May-24 6:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 29-May-24 | Option Exercise | 6,652 | -- | -- | 37% 18.0K to 24.65K | |
03-Apr-24 8:41 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 02-Apr-24 | Option Exercise | 10,912 | $105.08 | $1,146,630.00 | 911% 1.2K to 12.11K | |
03-Apr-24 8:41 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 02-Apr-24 | Planned Option Sale | 10,912 | $244.51 | $2,668,090.00 | (90%) 12.11K to 1.2K | |
03-Apr-24 8:41 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 01-Apr-24 | Option Exercise | 21,577 | $100.79 | $2,174,710.00 | 1801% 1.2K to 22.77K | |
03-Apr-24 8:41 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 01-Apr-24 | Planned Option Sale | 21,577 | $257.24 | $5,550,540.00 | (95%) 22.77K to 1.2K | |
15-Aug-23 4:04 PM View: | Halozyme Therapeutics, Inc. (HALO) | 14-Aug-23 | Sale | 10,000 | $43.74 | $437,410.00 | (33%) 30.5K to 20.5K | |
15-Aug-23 4:04 PM View: | Halozyme Therapeutics, Inc. (HALO) | 11-Aug-23 | Private Sale | 10,000 | $43.71 | $437,110.00 | (25%) 40.5K to 30.5K | |
05-Jun-23 9:38 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 01-Jun-23 | Option Exercise | 8,552 | -- | -- | 90% 9.45K to 18.0K | |
09-May-23 6:14 PM View: | Halozyme Therapeutics, Inc. (HALO) | 05-May-23 | Grant | 8,065 | -- | -- | 25% 32.44K to 40.5K | |
05-Jan-23 1:12 PM View: | Bellicum Pharmaceuticals, Inc (BLCM) | 03-Jan-23 | Option Exercise | 60,414 | -- | -- | 122% 49.46K to 109.87K | |
02-Sep-22 10:30 AM View: | Bellicum Pharmaceuticals, Inc (BLCM) | 01-Sep-22 | Option Exercise | 35,082 | -- | -- | 244% 14.38K to 49.46K | |
05-Jun-23 9:38 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 07-Jun-22 | Option Exercise | 6,391 | -- | -- | 209% 3.06K to 9.45K | |
06-May-22 8:05 PM View: | Halozyme Therapeutics, Inc. (HALO) | 05-May-22 | Grant | 6,206 | -- | -- | 24% 26.23K to 32.44K | |
06-Jan-22 9:39 AM View: | Bellicum Pharmaceuticals, Inc (BLCM) | 04-Jan-22 | Option Exercise | 14,377 | -- | -- | 100% 0 to 14.38K | |
05-Jun-23 9:38 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 22-Jun-21 | Option Exercise | 3,059 | -- | -- | 100% 0 to 3.06K | |
06-May-21 8:01 PM View: | Halozyme Therapeutics, Inc. (HALO) | 05-May-21 | Grant | 5,230 | -- | -- | 25% 21.0K to 26.23K | |
25-Nov-20 6:57 PM View: | Halozyme Therapeutics, Inc. (HALO) | 25-Nov-20 | Market Sale | 10,363 | $40.41 | $418,800.00 | (33%) 31.36K to 21.0K | |
13-Aug-20 6:43 PM View: | Halozyme Therapeutics, Inc. (HALO) | 13-Aug-20 | Market Sale | 34,337 | $29.12 | $999,894.00 | (52%) 65.7K to 31.36K | |
13-May-20 6:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 11-May-20 | Option Exercise | 26,250 | $26.39 | $692,700.00 | 100% 0 to 26.25K | (3%) |
13-May-20 6:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 11-May-20 | Market Option Sale | 26,250 | $51.13 | $1,342,180.00 | (100%) 26.25K to 0 | |
01-May-20 7:11 PM View: | Halozyme Therapeutics, Inc. (HALO) | 30-Apr-20 | Grant | 8,829 | -- | -- | 16% 56.87K to 65.7K | |
11-Sep-19 7:18 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 09-Sep-19 | Option Exercise | 30,000 | $17.52 | $525,600.00 | 100% 0 to 30.0K | |
11-Sep-19 7:18 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 09-Sep-19 | Market Option Sale | 30,000 | $37.80 | $1,133,860.00 | (100%) 30.0K to 0 | |
03-May-19 4:12 PM View: | Halozyme Therapeutics, Inc. (HALO) | 02-May-19 | Grant | 12,173 | -- | -- | 27% 44.7K to 56.87K | |
02-May-18 7:39 PM View: | Halozyme Therapeutics, Inc. (HALO) | 02-May-18 | Grant | 10,363 | -- | -- | 30% 34.34K to 44.7K | |
05-May-17 4:53 PM View: | Halozyme Therapeutics, Inc. (HALO) | 04-May-17 | Grant | 14,135 | -- | -- | 70% 20.2K to 34.34K | |
06-May-16 4:35 PM View: | Halozyme Therapeutics, Inc. (HALO) | 04-May-16 | Grant | 20,202 | -- | -- | 100% 0 to 20.2K | |
25-Jun-15 4:28 PM View: | Incyte Corp (INCY) | 23-Jun-15 | Option Exercise | 11,691 | $21.05 | $246,046.00 | 332% 3.52K to 15.21K | |
25-Jun-15 4:28 PM View: | Incyte Corp (INCY) | 23-Jun-15 | Market Option Sale | 11,691 | $108.24 | $1,265,470.00 | (77%) 15.21K to 3.52K | 19% |
28-May-15 4:31 PM View: | Incyte Corp (INCY) | 26-May-15 | Option Exercise | 12,093 | $20.90 | $252,728.00 | 343% 3.52K to 15.61K | |
28-May-15 4:31 PM View: | Incyte Corp (INCY) | 26-May-15 | Market Option Sale | 12,093 | $106.39 | $1,286,640.00 | (77%) 15.61K to 3.52K | 18% |
24-Apr-15 4:20 PM View: | Incyte Corp (INCY) | 23-Apr-15 | Option Exercise | 36,941 | $35.97 | $1,328,840.00 | 1049% 3.52K to 40.46K | |
24-Apr-15 4:20 PM View: | Incyte Corp (INCY) | 23-Apr-15 | Market Option Sale | 36,941 | $107.67 | $3,977,440.00 | (91%) 40.46K to 3.52K | 19% |
25-Feb-15 5:29 PM View: | Incyte Corp (INCY) | 24-Feb-15 | Option Exercise | 8,334 | $16.62 | $138,511.00 | 237% 3.52K to 11.86K | |
25-Feb-15 5:29 PM View: | Incyte Corp (INCY) | 24-Feb-15 | Market Option Sale | 8,334 | $81.77 | $681,471.00 | (70%) 11.86K to 3.52K | (7%) |
25-Feb-15 5:29 PM View: | Incyte Corp (INCY) | 23-Feb-15 | Option Exercise | 2,778 | $18.32 | $50,893.00 | 79% 3.52K to 6.3K | |
25-Feb-15 5:29 PM View: | Incyte Corp (INCY) | 23-Feb-15 | Market Option Sale | 2,778 | $83.44 | $231,796.00 | (44%) 6.3K to 3.52K | (5%) |
26-Jan-15 4:57 PM View: | Incyte Corp (INCY) | 23-Jan-15 | Option Exercise | 11,109 | $17.05 | $189,352.00 | 316% 3.52K to 14.63K | |
26-Jan-15 4:57 PM View: | Incyte Corp (INCY) | 23-Jan-15 | Market Option Sale | 11,109 | $77.68 | $862,947.00 | (76%) 14.63K to 3.52K | (12%) |
09-Jan-15 7:00 PM View: | Incyte Corp (INCY) | 08-Jan-15 | Grant | 3,022 | -- | -- | 606% 0.5K to 3.52K | |
29-Dec-14 4:05 PM View: | Incyte Corp (INCY) | 23-Dec-14 | Option Exercise | 11,113 | $17.05 | $189,421.00 | 100% 0 to 11.11K | |
29-Dec-14 4:05 PM View: | Incyte Corp (INCY) | 23-Dec-14 | Market Option Sale | 11,113 | $74.43 | $827,141.00 | (100%) 11.11K to 0 | (17%) |
26-Nov-14 4:13 PM View: | Incyte Corp (INCY) | 24-Nov-14 | Option Exercise | 11,111 | $17.05 | $189,387.00 | 100% 0 to 11.11K | |
26-Nov-14 4:13 PM View: | Incyte Corp (INCY) | 24-Nov-14 | Market Option Sale | 11,111 | $74.08 | $823,103.00 | (100%) 11.11K to 0 | (18%) |
24-Oct-14 4:14 PM View: | Incyte Corp (INCY) | 23-Oct-14 | Option Exercise | 11,111 | $17.05 | $189,387.00 | 100% 0 to 11.11K | |
24-Oct-14 4:14 PM View: | Incyte Corp (INCY) | 23-Oct-14 | Market Option Sale | 11,111 | $53.49 | $594,327.00 | (100%) 11.11K to 0 | (63%) |
25-Sep-14 4:14 PM View: | Incyte Corp (INCY) | 23-Sep-14 | Option Exercise | 11,111 | $17.04 | $189,386.00 | 100% 0 to 11.11K | |
25-Sep-14 4:14 PM View: | Incyte Corp (INCY) | 23-Sep-14 | Market Option Sale | 11,111 | $47.65 | $529,439.00 | (100%) 11.11K to 0 | (83%) |
27-Aug-14 4:25 PM View: | Incyte Corp (INCY) | 25-Aug-14 | Option Exercise | 11,111 | $17.05 | $189,387.00 | 100% 0 to 11.11K | |
27-Aug-14 4:25 PM View: | Incyte Corp (INCY) | 25-Aug-14 | Market Option Sale | 11,111 | $51.96 | $577,328.00 | (100%) 11.11K to 0 | (68%) |